Ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, United States, 1991-2006

about

Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins

P2860

Q37308090-4B22A704-4094-46F6-95FA-E769209CEC9B

P2860

Ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, United States, 1991-2006

Item

http://www.wikidata.org/entity/Q37664535

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ciprofloxacin resistance and g ...... ties, United States, 1991-2006

@en

Ciprofloxacin resistance and g ...... ies, United States, 1991-2006.

@nl

type

Item

label

Ciprofloxacin resistance and g ...... ties, United States, 1991-2006

@en

Ciprofloxacin resistance and g ...... ies, United States, 1991-2006.

@nl

prefLabel

Ciprofloxacin resistance and g ...... ties, United States, 1991-2006

@en

Ciprofloxacin resistance and g ...... ies, United States, 1991-2006.

@nl

P1476

Ciprofloxacin resistance and g ...... ties, United States, 1991-2006

@en

P2093

Harrell W Chesson

http://www.w3.org/2001/XMLSchema#string

Hillard S Weinstock

http://www.w3.org/2001/XMLSchema#string

Kwame Owusu-Edusei

http://www.w3.org/2001/XMLSchema#string

Robert D Kirkcaldy

http://www.w3.org/2001/XMLSchema#string

Thomas L Gift

http://www.w3.org/2001/XMLSchema#string

P2860

Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections

Using spatial regression methods to examine the association between county-level racial/ethnic composition and reported cases of Chlamydia and gonorrhea: an illustration with data from the state of Texas.

Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.

Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.

The impact of the phase of an epidemic of sexually transmitted infection on the evolution of the organism.

High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure

Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.

Social determinants and sexually transmitted disease disparities.

The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008.

Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

P304

612-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID2004.131288

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261032273

http://www.w3.org/2001/XMLSchema#string

P698

24655615

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

3966369

http://www.w3.org/2001/XMLSchema#string

Ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, United States, 1991-2006

about

P2860

P2860

Ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, United States, 1991-2006

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932